Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cédric Raymond

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 5, 2022
Maximizing lymph node dissection from fresh lung cancer specimensCédric Raymond, Arthur Vieira, Philippe Joubert, et al.
Journal of Medicinal Chemistry|February 29, 2008
Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphateAngélique Boëdec, Hélène Sicard, Jean Dessolin, et al.
American Journal of Cardiovascular Disease|September 22, 2023
Concomitant symptomatic cardiac sarcoidosis and systemic sclerosis with cardiac involvement: a case reportSylvain Lemay, Carla Jeantin, Frédérique Kyomi Labelle, et al.
Journal of Medicinal Chemistry|October 25, 2012
From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteriaVincent Gerusz, Alexis Denis, Fabien Faivre, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 5, 2022
Maximizing lymph node dissection from fresh lung cancer specimensCédric Raymond, Arthur Vieira, Philippe Joubert, et al.
Journal of Medicinal Chemistry|February 29, 2008
Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphateAngélique Boëdec, Hélène Sicard, Jean Dessolin, et al.
American Journal of Cardiovascular Disease|September 22, 2023
Concomitant symptomatic cardiac sarcoidosis and systemic sclerosis with cardiac involvement: a case reportSylvain Lemay, Carla Jeantin, Frédérique Kyomi Labelle, et al.
Journal of Medicinal Chemistry|October 25, 2012
From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteriaVincent Gerusz, Alexis Denis, Fabien Faivre, et al.
Pageof 1